In agreement, minimal dosing of leukocyte-targeting TRAIL via administration of E-selectin-TRAIL liposomes decreased triple-negative breast cancer metastasis following tumor resection in a preclinical mouse model [30]. This evidence concerns the gene TNFSF10 and triple-negative breast carcinoma.